期刊文献+

组蛋白精氨酸甲基转移酶5在胃癌组织中的表达及其意义 被引量:3

Expression of PRMT5 in human gastric cancer tissue and its significance
下载PDF
导出
摘要 目的:探讨组蛋白精氨酸甲基转移酶5(PRMT5)在胃癌组织中的表达,阐明PRMT5与胃癌发生及临床病理学特征之间的关系,为胃癌的防治提供新的靶点。方法:43例人胃癌组织及15例癌旁正常胃组织样本分别作为胃癌组和对照组,采用免疫组织化学方法检测2组样本中PRMT5的高表达率。结果:与对照组(13.3%)比较,胃癌组胃癌组织中PRMT5高表达率(72.1%)明显升高(P<0.05)。对照组弱阳性表达标本中,棕黄色颗粒主要位于细胞浆中,表现为弱到中等强度表达,细胞核染色较少;高分化胃癌标本中,棕黄色颗粒主要位于细胞浆中,表现为中等和强表达,细胞核染色较多;中、低分化和未分化胃癌标本中棕黄色颗粒主要位于细胞浆和细胞核中,细胞核表现为强表达。PRMT5高表达率与肿瘤大小、分化程度、浸润深度、淋巴结转移情况及TNM分期有关联(P<0.05或P<0.01),与患者的性别和年龄无关联(P<0.05)。结论:PRMT5高表达可能对胃癌的发生发展起促进作用。 Objective:To investigate the expression of protein arginine methyltransferase 5(PRMT5)in the gastric cancer tissue,and to explore the relationship between the PRMT5 expression and the occurrence and the clinicopathologic characteristics of gastric cancer,and to find a new treatment target for gastric cancer.Methods:Forty-three cases of gastric cancer tissue and 15 cases of adjacent normal gastric tissue were used as gastric cancer group and control group,respectively.The immunohistochemical staining was used to detect the expression of PRMT5 in the specimens.Results:Compared with control group(13.3%),the expression rate of PRMT5 in gastric cancer group(72.1%)was significantly increased(P〈0.05).In control group,there was some weak positive expression of PRMT5,the expressions were weak or moderate,the tan particles mainly located in the cytoplasm,less in the nuclei.In high differentiation gastric cancer specimens,the tan particles mainly located in the cytoplasm and more in nuclei,characterized by medium or strong expressions.In poorly differentiated and undifferentiated gastric cancer specimens,the tan particles mainly located in the cytoplasm and nucleus,and strongly expressed in nucleus.The higher expression of PRMT5 was associated with the size of tumor diameter,degree of differentition,depth of invasion,degree of lymph node metastasis,and TNM stage(P〈0.05 or P〈0.01),but had no correlation with the gender and age of patients(P〈0.05).Conclusion:High expression of PRMT5 may play an important role in the occurrence and development of gastric cancer.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2016年第4期753-756,I0004,共5页 Journal of Jilin University:Medicine Edition
基金 国家自然科学基金资助课题(81272537 30801497) 江苏省教育厅高校自然科学基金资助课题(11KJB360010) 扬州大学"新世纪人才工程"资助课题(2012)
关键词 胃肿瘤 组蛋白精氨酸甲基转移酶5 免疫组织化学 stomach neoplasms protein arginine methyltransferase 5 immunohistochemistry
  • 相关文献

参考文献3

二级参考文献63

  • 1Shorter J, Warren G. Golgi architecture and inheritance. Annu Rev Cell Dev Biol2002; 18:379-420.
  • 2Colanzi A, Suetterlin C, Malhotra V. Cell-cycle-specific Golgi fragmentation: how and why? Curr Opin Cell Biol 2003; 15:462-467.
  • 3Barr FA, Short B. Golgins in the structure and dynamics of the Golgi apparatus. Curr Opin Ceil Biol2003 ; 15:405-413.
  • 4Ramirez IB, Lowe M. Golgins and GRASPs: holding the Golgi together. Semin Cell Dev Biol2009; 20:770-779.
  • 5Nakamura N, Rabouille C, Watson R, et al. Characterization of a cis-Golgi matrix protein, GM130. Y Cell Biol 1995; 131:1715-1726.
  • 6Nakamura N, Lowe M, Levine TP, Rabouille C, Warren G. The vesicle docking protein p115 binds GM130, a cis-Golgi matrix protein, in a mitotically regulated manner. Cell 1997; 89:445-455.
  • 7Marra P, Maffucci T, Daniele T, et al. The GM130 and GRASP65 Golgi proteins cycle through and define a subdo- main of the intermediate compartment. Nat Cell Biol 2001; 3:1101-1113.
  • 8Sonnichsen B, Lowe M, Levine T, et al. A role for giantin in docking COPI vesicles to Golgi membranes. J Cell Biol 1998; 140:1013-1021.
  • 9Beard M, Satoh A, Shorter J, Warren G. A cryptic Rablbinding site in the pl 15 tethering protein. J Biol Chem 2005; 280:25840-25848.
  • 10Puthenveedu MA, Bachert C, Puri S, Lanni F, Linstedt AD. GM130 and GRASP65-dependent lateral cisternal fusion allows uniform Golgi-enzyme distribution. Nat Cell Biol 2006; 8:238-248.

共引文献19

同被引文献25

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部